CompletedPhase 2NCT00052390
Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma
Studying Soft tissue sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Robert Maki, MD, PhDMemorial Sloan Kettering Cancer Center
- Intervention
- bevacizumab(biological)
- Eligibility
- 18 years · All sexes
- Timeline
- 2002 – 2005
Study locations (3)
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center, New York, New York, United States
- Huntsman Cancer Institute, Salt Lake City, Utah, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00052390 on ClinicalTrials.govOther trials for Soft tissue sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07402577Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility StudyRoswell Park Cancer Institute
- RECRUITINGNANCT07359911Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma PatientsUniversity of Miami
- RECRUITINGNCT07148193Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)Technische Universität Dresden
- RECRUITINGPHASE1NCT07156565Actinium Therapy for Late-stage Aggressive SarcomasRatio Therapeutics, Inc.
- RECRUITINGNANCT07104955Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and SafetySalutare Group Ltd.
- RECRUITINGPHASE1, PHASE2NCT07064018Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesUniversity of California, Irvine
- RECRUITINGNCT06962072Outcomes Following Limb Sparing Surgery for Soft Tissue SarcomaAmsterdam UMC
- RECRUITINGPHASE2NCT06905132Preoperative 5-Day Radiotherapy for Soft Tissue SarcomaMedical University of South Carolina